BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16973360)

  • 1. Structure-activity relationships for a novel series of thiazolyl phenyl ether derivatives exhibiting potent and selective acetyl-CoA carboxylase 2 inhibitory activity.
    Clark RF; Zhang T; Xin Z; Liu G; Wang Y; Hansen TM; Wang X; Wang R; Zhang X; Frevert EU; Camp HS; Beutel BA; Sham HL; Gu YG
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6078-81. PubMed ID: 16973360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenoxy thiazole derivatives as potent and selective acetyl-CoA carboxylase 2 inhibitors: Modulation of isozyme selectivity by incorporation of phenyl ring substituents.
    Clark RF; Zhang T; Wang X; Wang R; Zhang X; Camp HS; Beutel BA; Sham HL; Gu YG
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1961-5. PubMed ID: 17267221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent biphenyl- and 3-phenyl pyridine-based inhibitors of acetyl-CoA carboxylase.
    Haque TS; Liang N; Golla R; Seethala R; Ma Z; Ewing WR; Cooper CB; Pelleymounter MA; Poss MA; Cheng D
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5872-6. PubMed ID: 19740659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (4-Piperidinyl)-piperazine: a new platform for acetyl-CoA carboxylase inhibitors.
    Chonan T; Oi T; Yamamoto D; Yashiro M; Wakasugi D; Tanaka H; Ohoka-Sugita A; Io F; Koretsune H; Hiratate A
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6645-8. PubMed ID: 19853443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of disubstituted (4-piperidinyl)-piperazine derivatives as potent acetyl-CoA carboxylase inhibitors.
    Chonan T; Tanaka H; Yamamoto D; Yashiro M; Oi T; Wakasugi D; Ohoka-Sugita A; Io F; Koretsune H; Hiratate A
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3965-8. PubMed ID: 20537533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1- methylprop-2-ynyl}carboxy derivatives as selective acetyl-CoA carboxylase 2 inhibitors.
    Gu YG; Weitzberg M; Clark RF; Xu X; Li Q; Zhang T; Hansen TM; Liu G; Xin Z; Wang X; Wang R; McNally T; Zinker BA; Frevert EU; Camp HS; Beutel BA; Sham HL
    J Med Chem; 2006 Jun; 49(13):3770-3. PubMed ID: 16789734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and structure-activity relationships of spirolactones bearing 2-ureidobenzothiophene as acetyl-CoA carboxylases inhibitors.
    Yamashita T; Kamata M; Endo S; Yamamoto M; Kakegawa K; Watanabe H; Miwa K; Yamano T; Funata M; Sakamoto J; Tani A; Mol CD; Zou H; Dougan DR; Sang B; Snell G; Fukatsu K
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6314-8. PubMed ID: 21944854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and structure-activity relationships of novel spiro-piperidines as acetyl-CoA carboxylase inhibitors.
    Kamata M; Yamashita T; Kina A; Funata M; Mizukami A; Sasaki M; Tani A; Funami M; Amano N; Fukatsu K
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3643-7. PubMed ID: 22560583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression, purification, and characterization of human acetyl-CoA carboxylase 2.
    Kim KW; Yamane H; Zondlo J; Busby J; Wang M
    Protein Expr Purif; 2007 May; 53(1):16-23. PubMed ID: 17223360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a novel olefin derivative as a highly potent and selective acetyl-CoA carboxylase 2 inhibitor with in vivo efficacy.
    Nishiura Y; Matsumura A; Kobayashi N; Shimazaki A; Sakamoto S; Kitade N; Tonomura Y; Ino A; Okuno T
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2498-2503. PubMed ID: 29903660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symmetrical approach of spiro-pyrazolidinediones as acetyl-CoA carboxylase inhibitors.
    Kamata M; Yamashita T; Kina A; Tawada M; Endo S; Mizukami A; Sasaki M; Tani A; Nakano Y; Watanabe Y; Furuyama N; Funami M; Amano N; Fukatsu K
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4769-72. PubMed ID: 22677317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperazine oxadiazole inhibitors of acetyl-CoA carboxylase.
    Bourbeau MP; Siegmund A; Allen JG; Shu H; Fotsch C; Bartberger MD; Kim KW; Komorowski R; Graham M; Busby J; Wang M; Meyer J; Xu Y; Salyers K; Fielden M; Véniant MM; Gu W
    J Med Chem; 2013 Dec; 56(24):10132-41. PubMed ID: 24294923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of small molecule isozyme non-specific inhibitors of mammalian acetyl-CoA carboxylase 1 and 2.
    Corbett JW; Freeman-Cook KD; Elliott R; Vajdos F; Rajamohan F; Kohls D; Marr E; Zhang H; Tong L; Tu M; Murdande S; Doran SD; Houser JA; Song W; Jones CJ; Coffey SB; Buzon L; Minich ML; Dirico KJ; Tapley S; McPherson RK; Sugarman E; Harwood HJ; Esler W
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2383-8. PubMed ID: 20219367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of small molecule inhibitors of acetyl-CoA carboxylase 1 and 2 showing reduction of hepatic malonyl-CoA levels in vivo in obese Zucker rats.
    Bengtsson C; Blaho S; Saitton DB; Brickmann K; Broddefalk J; Davidsson O; Drmota T; Folmer R; Hallberg K; Hallén S; Hovland R; Isin E; Johannesson P; Kull B; Larsson LO; Löfgren L; Nilsson KE; Noeske T; Oakes N; Plowright AT; Schnecke V; Ståhlberg P; Sörme P; Wan H; Wellner E; Oster L
    Bioorg Med Chem; 2011 May; 19(10):3039-53. PubMed ID: 21515056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel bacterial acetyl coenzyme A carboxylase inhibitors with antibiotic efficacy in vivo.
    Freiberg C; Pohlmann J; Nell PG; Endermann R; Schuhmacher J; Newton B; Otteneder M; Lampe T; Häbich D; Ziegelbauer K
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2707-12. PubMed ID: 16870762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimeric cyclohexane-1,3-dione oximes inhibit wheat acetyl-CoA carboxylase and show anti-malarial activity.
    Louie T; Goodman CD; Holloway GA; McFadden GI; Mollard V; Watson KG
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4611-3. PubMed ID: 20580556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
    Sagar V; Zheng W; Thompson PR; Cole PA
    Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of N-(1-(3-(4-phenoxyphenyl)-1,2,4-oxadiazol-5-yl)ethyl)acetamides as novel acetyl-CoA carboxylase 2 (ACC2) inhibitors with peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonistic activity.
    Okazaki S; Noguchi-Yachide T; Sakai T; Ishikawa M; Makishima M; Hashimoto Y; Yamaguchi T
    Bioorg Med Chem; 2016 Nov; 24(21):5258-5269. PubMed ID: 27591006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herbicidal aryldiones incorporating a 5-methoxy-[1,2,5]triazepane ring.
    Smejkal T; Hachisu S; Scutt JN; Willetts NJ; Sayer D; Wildsmith L; Oliver S; Thompson C; Muehlebach M
    Bioorg Med Chem Lett; 2018 Feb; 28(3):339-343. PubMed ID: 29317169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of new (2E,6E)-10-(dimethylamino)-3,7-dimethyl-2,6-decadien-1-ol ethers as inhibitors of human and Trypanosoma cruzi oxidosqualene cyclase.
    Galli U; Oliaro-Bosso S; Taramino S; Venegoni S; Pastore E; Tron GC; Balliano G; Viola F; Sorba G
    Bioorg Med Chem Lett; 2007 Jan; 17(1):220-4. PubMed ID: 17027267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.